X @Bloomberg
Bloomberg·2026-02-09 21:48
US regulators rejected a gene therapy from Regenxbio to treat a rare disease that causes brain damage in boys, the latest sign that the Trump administration is taking a hard line on drug approvals for uncommon conditions https://t.co/LbeZaVu5dC ...